This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Parks, C G Articles by Pandey, J P Search for Related Content PubMed PubMed Citation Articles by Parks, C G Articles by Pandey, J P Pubmed/NCBI databases Gene GEO Profiles HomoloGene UniGene Substance via MeSH Medline Plus Health Information Lupus Social Bookmarking                         What's this?

CTLA-4 gene polymorphisms and systemic lupus erythematosus in a population-based study of whites and African-Americans in the southeastern United States

National Institute of Environmental Health Sciences, NIH, DHHS, Durham, NC, USA, parks{at}niehs.nih.gov

L L Hudson

Medical University of South Carolina, Charleston, SC, USA

G S Cooper

National Institute of Environmental Health Sciences, NIH, DHHS, Durham, NC, USA

M A Dooley

University of North Carolina Medical School, Chapel Hill, NC, USA

E L Treadwell

East Carolina University School of Medicine, Greenville, NC, USA

E W St Clair

Duke University Medical Center, Durham, NC, USA

G S Gilkeson

Medical University of South Carolina, Charleston, SC, USA

J P Pandey

Medical University of South Carolina, Charleston, SC, USA

Cytotoxic lymphocyte antigen-4 (CTLA-4) plays an important role in regulating T cell activation, and may help to limit T cell response under conditions of inflammation. Genetic variability in CTLA-4 has been implicated in the development of several autoimmune diseases. Some studies have described associations between CTLA-4 polymorphisms and systemic lupus erythematosus (SLE), but findings have been inconsistent. We examined polymorphisms in the CTLA-4 gene promoter region (21722T/C, 21661A/G, 2318C/T) and exon 1 (+49G/A) with respect to SLE in a population-based case-control study in the southeastern US. Genotypes from 230 recently diagnosed cases and 276 controls were examined separately for African-Americans and whites. We observed no overall associations between SLE and the four CTLA-4 polymorphisms examined. Subgroup analyses revealed effect modification by age for the presence of the 21661G allele, yielding a significant positive association with SLE in younger (35 years) African-Americans (OR = 3.3). CTLA-4 genotypes also interacted with HLA-DR2 and GM allotype to contribute to risk of SLE. These findings suggest allelic variation in this region of CTLA-4 is not a major independent risk factor for SLE, but may contribute to risk of disease in younger African-Americans or in the presence of certain immunogenetic markers.

Key Words: CTLA-4 • effect modification • genetics • polymorphism • population-based • systemic lupus erythematosus

Lupus, Vol. 13, No. 10, 784-791 (2004)
DOI: 10.1191/0961203304lu1085oa


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				A. Perez-Garcia, R. De la Camara, J. Roman-Gomez, A. Jimenez-Velasco, M. Encuentra, J. B. Nieto, J. de la Rubia, A. Urbano-Ispizua, S. Brunet, A. Iriondo, et al. CTLA-4 polymorphisms and clinical outcome after allogeneic stem cell transplantation from HLA-identical sibling donors. Blood, July 1, 2007; 110(1): 461 - 467. [Abstract] [Full Text] [PDF]

				D.S. C. Graham, A.K. Wong, N.J. McHugh, J.C. Whittaker, and T. J. Vyse Evidence for unique association signals in SLE at the CD28-CTLA4-ICOS locus in a family-based study Hum. Mol. Genet., November 1, 2006; 15(21): 3195 - 3205. [Abstract] [Full Text] [PDF]